English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Journal of Cardiac Critical Care TSS Vol. 1 No. 2/2017 Introduction: Extracorporeal membrane oxygenation (ECMO) is becoming an important therapeutic option for patients with severe acute respiratory distress syndrome (ARDS). Pneumothorax is a known complication of mechanical ventilator strategy in ARDS. Anticoagulation given during ECMO increases the chance of uncontrolled bleeding. We report management of hemopneumothorax in a patient with kyphoscoliosis, hypothyroidism, and acute viral pneumonia in a patient with severe ARDS who was on ECMO support. Case Report: We report a 55-year-old woman, a known case of kyphoscoliosis and primary hypothyroidism received with refractory hypoxemia. The patient was immediately intubated and put on mechanical ventilation. In view of high fraction of inspired oxygen (Fio2) requirement (severe ARDS) on ventilator, prone positioning was done. Due to high positive end-expiratory pressure (PEEP), she developed sight-sided pneumothorax leading to implantable cardioverterdefibrillator (ICD) insertion. Still she was not maintaining peripheral capillary oxygen saturation (Spo2), and chest X-ray (CXR) worsened. She was put on ECMO. During ECMO, she developed bleed from ICD site. Local site adrenaline infiltration was done. Massive blood transfusion was done (13 units in 24 hours). Target activated clotting time (ACT) level was kept on lower side and bleeding stopped. CXR revealed right hemothorax (clots). Till seventh day of ECMO, the patient did not show any improvement, so thoracotomy was done on ECMO and clots were retrieved. Postthoracotomy CXR revealed lung expansion. Following this, the patient had massive bleed for which massive blood transfusion (packed red blood cell [RBC], random donor platelets [RDP], single donor platelets [SDP], cryoprecipitate, fresh frozen plasma [FFP]) was done. On 01/11/17 (eighth day), the patient was weaned off from ECMO. Post ECMO, her Fio2 requirement was 65%. Computed tomographic (CT) scan of her chest revealed bilateral diffuse ground-glass opacities with septal thickening, and her bleeding stopped. In next 3 days, her Fio2 requirement was increased so she was started on steroid and diuretics, and antibiotics were escalated. The patient’s condition did not improve, and she was discharged against medical advice. Conclusion: Management of hemopneumothorax on ECMO is a very challenging task due to anticoagulation. Massive bleeding needs blood transfusion, targeting low ACT during ECMO. Surgical exploration on ECMO is also challenging, but with careful planning, surgery can be managed well.

Venoarterial Extracorporeal Membrane Oxygenation in Case of Drug-Induced Stress Cardiomyopathy—A Lifesaving Intervention